FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea
(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a...
Nasdaq News: Markets·2mo ago